FDA lukewarm on PTC’s Translarna
admin 27th September 2017 Uncategorised 0Agency says studies into Duchenne muscular dystrophy drug were inconclusive
More: FDA lukewarm on PTC’s Translarna
Source: News
Agency says studies into Duchenne muscular dystrophy drug were inconclusive
More: FDA lukewarm on PTC’s Translarna
Source: News
© 1994 - 2024 B.M. Pharmaceuticals